Carla L. Warneke

The University of Texas MD Anderson Cancer Center

Papers

2

Total Citations

151

H-Index

2

About

Carla L. Warneke is a leading health services researcher whose work centers on comparative effectiveness and patient-reported outcomes in head and neck cancer treatment. Her major contributions lie in evaluating how surgical innovations—particularly transoral robotic surgery (TORS) and robot-assisted thyroidectomy—affect functional recovery and quality of life relative to traditional therapies. In her landmark 2019 study (87 citations), she demonstrated that patients with low- to intermediate-risk oropharyngeal cancer who underwent primary TORS with neck dissection experienced significantly better swallowing outcomes than those receiving nonsurgical therapy, providing critical evidence for personalized treatment decisions. Her 2011 investigation (64 citations) was among the first to compare robot-assisted transaxillary thyroid surgery to open lobectomy in the United States, establishing benchmarks for safety and efficacy. With a career spanning over two decades, Warneke has shaped clinical guidelines by rigorously quantifying trade-offs between oncologic control and functional preservation. Her work is essential reading for clinicians and researchers navigating the balance between technological advancement and patient-centered care in surgical oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
151
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
87 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago